SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-110687
Filing Date
2016-03-25
Accepted
2016-03-25 19:20:46
Documents
2
Period of Report
2016-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1609
2 POA DOCUMENT poa.txt EX-24.3_644902 3101
  Complete submission text file 0001209191-16-110687.txt   6187
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-272-6138
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 330971591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 350 CAMBRIDGE AVE, SUITE 350 PALO ALTO CA 94306
Business Address
Martins Eduardo Bruno (Reporting) CIK: 0001670431 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 161530307